Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Kates

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
The Journal of Urology|July 10, 2019
Editorial CommentMax Kates
European Urology Focus|July 7, 2023
Doing Less with More: Towards a New Paradigm of Non-muscle-invasive Bladder Cancer CareMax Kates
The Journal of Urology|December 8, 2025
Editorial CommentMax Kates
European Urology|January 24, 2021
Open Versus Robot-assisted Radical Cystectomy: Is Standardization Without Randomization Possible?Sunil H Patel, Max Kates
Urology Practice|August 18, 2023
Immunotherapy for Prostate Cancer-Why Now?Max Kates, Charles G Drake
Nature Reviews. Urology|August 2, 2022
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everythingKatherine M Rodriguez, Max Kates
The Journal of Urology|August 1, 2018
Editorial CommentMax Kates, Trinity J Bivalacqua
Current Opinion in Oncology|March 21, 2019
Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatmentsMohit Gupta, Max Kates, Trinity J Bivalacqua
Chest|June 26, 2010
Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER dataMax Kates, Scott Swanson, Juan P Wisnivesky
Nature Reviews. Urology|August 23, 2019
Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancerGregory A Joice, Trinity J Bivalacqua, Max Kates
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Urology|July 10, 2019
Editorial CommentMax Kates
European Urology Focus|July 7, 2023
Doing Less with More: Towards a New Paradigm of Non-muscle-invasive Bladder Cancer CareMax Kates
The Journal of Urology|December 8, 2025
Editorial CommentMax Kates
European Urology|January 24, 2021
Open Versus Robot-assisted Radical Cystectomy: Is Standardization Without Randomization Possible?Sunil H Patel, Max Kates
Urology Practice|August 18, 2023
Immunotherapy for Prostate Cancer-Why Now?Max Kates, Charles G Drake
Nature Reviews. Urology|August 2, 2022
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everythingKatherine M Rodriguez, Max Kates
The Journal of Urology|August 1, 2018
Editorial CommentMax Kates, Trinity J Bivalacqua
Current Opinion in Oncology|March 21, 2019
Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatmentsMohit Gupta, Max Kates, Trinity J Bivalacqua
Chest|June 26, 2010
Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER dataMax Kates, Scott Swanson, Juan P Wisnivesky
Nature Reviews. Urology|August 23, 2019
Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancerGregory A Joice, Trinity J Bivalacqua, Max Kates
Pageof 16